CRISPR/Cas9 genome editing is used to create an in-frame deletion in exon 3 - specifically within the 87 nucleotides encoding the 1-29 residues. Founder male 18-1 was identified with a 91 bp deletion including 28 of the first 29 amino acids of the gene. (J:101977)